{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:27:48Z","timestamp":1789165668598,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Lymphadenectomy is an important element of the surgical treatment of pancreatic ductal adenocarcinoma (PDAC). The study aimed to analyze the distribution of lymph node metastases in three nodal stations\u2014group 10 (splenic hilum), group 11 (along the splenic artery), and group 18 (inferior pancreatic margin) depending on the location of PDAC in the distal pancreas: pancreatic neck (PN) vs. pancreatic body (PB) vs. pancreatic tail (PT). Methods: Data from 163 patients who underwent radical (R0) distal pancreatectomy with splenectomy (DP-S) with standard lymphadenectomy (removal of lymph nodes in groups 10, 11, and 18) for PDAC between 2010 and 2023 were analyzed. Patients were assigned to three groups based on the location of the primary tumor: neck (PN, n = 52), body (PB, n = 66), and tail (PT, n = 45). Results: The pattern of nodal metastasis was found to be dependent on the location of PDAC: group 10 (p &lt; 0.001) is characteristic for tumor location in the PT (84.4%; 95% CI: 70\u201393%) and group 11 (p = 0.004) for tumors located in the PB (72.7%; 95% CI: 60\u201383%). Lymphatic drainage in group 18 constitutes a common zone, involved regardless of PDAC location (p = 0.185). In multivariate analysis, independent factors influencing overall survival were grading (HR 4.74; 95% CI 2.93\u20137.68; p &lt; 0.001), lymph node metastasis in group 10 (HR = 3.65; 95% CI: 2.34\u20135.70; p &lt; 0.001), group 11 (HR = 4.42; CI: 2.56\u20137.63; p &lt; 0.001), group 18 (HR = 3.26; CI: 1.93\u20135.51; p &lt; 0.001), and the use of neoadjuvant chemotherapy (HR = 0.57; CI: 0.39\u20130.84; p = 0.005). Conclusions: PDAC location in the distal pancreas influences metastasis to specific lymph node locations. Metastases to regional lymph node stations are associated with survival after DP-S procedures. In our retrospective cohort, neoadjuvant chemotherapy is associated with a lower risk of death and distant metastases due to PDAC after DP-S procedures.<\/jats:p>","DOI":"10.3390\/cancers18121988","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:25:34Z","timestamp":1781778334000},"page":"1988","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of the Distribution of Lymph Node Metastases and Their Impact on the Prognosis in Ductal Adenocarcinoma of the Distal Part of the Pancreas\u2014A Single-Center Retrospective Study"],"prefix":"10.3390","volume":"18","author":[{"given":"Magdalena","family":"Gajda","sequence":"first","affiliation":[{"name":"Department of Gastrointestinal Surgery, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2283-0286","authenticated-orcid":false,"given":"Ewa","family":"Grudzi\u0144ska","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u0142awomir","family":"Mrowiec","sequence":"additional","affiliation":[{"name":"Department of Gastrointestinal Surgery, Medical University of Silesia, 40-752 Katowice, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5114\/jhi.2019.87844","article-title":"Global burden of pancreas cancer: Regional disparities in incidence, mortality, and survival","volume":"5","author":"Pizot","year":"2019","journal-title":"J. Health Inequal."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"16425","DOI":"10.1038\/s41598-020-73525-y","article-title":"The actual 5-year survivors of pancreatic ductal adenocarcinoma based on real-world data","volume":"10","author":"Bengtsson","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1200\/JCO.2007.15.8634","article-title":"Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head","volume":"26","author":"Evans","year":"2008","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.3748\/wjg.v24.i43.4846","article-title":"Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes","volume":"24","author":"McGuigan","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"25285","DOI":"10.1021\/acsami.3c00865","article-title":"Biomimetic Gold Nanorods Modified with Erythrocyte Membranes for Imaging-Guided Photothermal\/Gene Synergistic Therapy","volume":"15","author":"Guo","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.surg.2014.06.016","article-title":"Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: A consensus statement by the International Study Group on Pancreatic Surgery (ISGPS)","volume":"156","author":"Tol","year":"2014","journal-title":"Surgery"},{"key":"ref_9","first-page":"213","article-title":"Anatomy of the pancreas and spleen","volume":"40","author":"Bazira","year":"2022","journal-title":"Surgery"},{"key":"ref_10","unstructured":"National Comprehensive Cancer Network (2025, February 03). Pancreatic Adenocarcinoam Guidelines (Version 3.2025). Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/pancreatic.pdf."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.sla.0000133125.85489.07","article-title":"Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas","volume":"240","author":"Brennan","year":"2004","journal-title":"Ann. Surg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1245\/s10434-017-6025-x","article-title":"8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers","volume":"25","author":"Chun","year":"2018","journal-title":"Ann. Surg. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/SLA.0000000000002781","article-title":"Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body\/Tail Ductal Adenocarcinoma","volume":"270","author":"Malleo","year":"2019","journal-title":"Ann. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"100673","DOI":"10.1016\/j.lanepe.2023.100673","article-title":"Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): An international randomised non-inferiority trial","volume":"30","author":"Korrel","year":"2023","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s11605-014-2566-5","article-title":"Nodal counts and lymph node ratio impact survival after distal pancreatectomy for pancreatic adenocarcinoma","volume":"18","author":"Ashfaq","year":"2014","journal-title":"J. Gastrointest. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s11605-007-0243-7","article-title":"Prognostic Significance of Pathologic Nodal Status in Patients with Resected Pancreatic Cancer","volume":"11","author":"House","year":"2007","journal-title":"J. Gastrointest. Surg."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s11605-009-0919-2","article-title":"The Lymph Node Ratio Is the Strongest Prognostic Factor after Resection of Pancreatic Cancer","volume":"13","author":"Riediger","year":"2009","journal-title":"J. Gastrointest. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s13193-018-0824-9","article-title":"Prognostic Value of Metastatic Lymph Node Ratio in Pancreatic Cancer","volume":"10","author":"Karaca","year":"2019","journal-title":"Indian. J. Surg. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ags3.12608","article-title":"Reevaluation of regional lymph nodes in patients with pancreatic ductal adenocarcinoma in the pancreatic body and tail","volume":"7","author":"Matsui","year":"2022","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/ags3.12771","article-title":"Prognostic significance of lymph node metastasis in pancreatic tail cancer: A multicenter retrospective study","volume":"8","author":"Hirashita","year":"2024","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.pan.2020.08.014","article-title":"Pancreatic body and tail cancer and favorable metastatic lymph node behavior on the left edge of the aorta","volume":"20","author":"Tanaka","year":"2020","journal-title":"Pancreatology"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Tanaka, K., Kimura, Y., Hayashi, T., Ambo, Y., Yoshida, M., Umemoto, K., Murakami, T., Asano, T., Nakamura, T., and Hirano, S. (2022). Appropriate Lymph Node Dissection Sites for Cancer in the Body and Tail of the Pancreas: A Multicenter Retrospective Study. Cancers, 14.","DOI":"10.3390\/cancers14184409"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1245\/s10434-020-08658-5","article-title":"Predictors for Survival in an International Cohort of Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma","volume":"28","author":"Korrel","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1245\/s10434-021-11108-5","article-title":"Optimal Region of Lymph Node Dissection in Distal Pancreatectomy for Left-Sided Pancreatic Cancer Based on Tumor Location","volume":"29","author":"Ishida","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15353508241245265","DOI":"10.1177\/15353508241245265","article-title":"Combining Nuclear Medicine With Other Modalities: Future Prospect for Multimodality Imaging","volume":"23","author":"Archibald","year":"2024","journal-title":"Mol. Imaging"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/cam4.1071","article-title":"Neoadjuvant therapy in pancreatic cancer: A systematic review and meta-analysis of prospective studies","volume":"6","author":"Zhan","year":"2017","journal-title":"Cancer Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1245\/s10434-014-4192-6","article-title":"Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer","volume":"22","author":"Roland","year":"2015","journal-title":"Ann. Surg. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.surg.2018.12.009","article-title":"Nodal downstaging as a treatment goal for node-positive pancreatic cancer","volume":"165","author":"Portuondo","year":"2019","journal-title":"Surgery"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1200\/JCO.19.02274","article-title":"Dutch Pancreatic Cancer Group. Preoperative chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: Results of the Dutch randomized phase III PREOPANC trial","volume":"38","author":"Versteijne","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Roesel, R., Deantonio, L., Bernardi, L., Garo, M.L., Majno-Hurst, P., Vannelli, A., Cefal\u00ec, M., Palmarocchi, M.C., Valli, M.C., and Pesola, G. (2023). Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes. Cancers, 15.","DOI":"10.3390\/cancers15184627"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/12\/1988\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:39:56Z","timestamp":1781779196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/12\/1988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":30,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cancers18121988"],"URL":"https:\/\/doi.org\/10.3390\/cancers18121988","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}